The relationship between anti-Xa activity and the renal function in elderly patients who are on apixaban
Phase of Trial: Phase IV
Latest Information Update: 27 Jul 2017
At a glance
- Drugs Apixaban (Primary)
- Indications Stroke; Thromboembolism
- Focus Pharmacodynamics; Pharmacokinetics
- 24 Jul 2017 Status changed from recruiting to completed.
- 22 Jul 2016 Status changed from not yet recruiting to recruiting.
- 30 May 2016 New trial record